Why the study?
Does metoprolol affect 24-hour urinary excretion of adrenal steroids and kallikrein in patients with essential hypertension?
Does metoprolol affect 24-hour urinary excretion of adrenal steroids and kallikrein in patients with essential hypertension?
Metoprolol decreases urinary kallikrein and aldosterone excretion and plasma renin activity in essential hypertension, likely due to reduced sympathetic tone and renin-aldosterone system activity.
Answers are grounded in this paper and cite their sources.
Metoprolol-associated reductions in urinary kallikrein and aldosterone warrant confirmation in RCTs; leaves open effects on outcomes in essential hypertension.
Treatment of fifteen patients with essential hypertension over four weeks using the beta 1-adrenoceptor blocking agent, metoprolol, resulted in a decrease in 24 h urinary excretion of kallikrein and aldosterone along with a decrease in plasma renin activity. There was no significant change in 24 h excretion rates of the free adrenal steroids deoxycorticosterone, 18-OH-deoxycorticosterone, corticosterone, cortisol or 18-OH-corticosterone during treatment, which were not significantly different from excretion rates of normal males, thus excluding inhibitory effects of adrenal steroids on urinary kallikrein activity. A positive correlation was found between plasma renin activity and urinary excretion of kallikrein during the control period and after 2 weeks on metoprolol, supporting the assumption of a preserved link between the renin-angiotensin-aldosterone system and the renal excretion of kallikrein in these patients. The decrease in kallikrein excretion during beta 1-adrenoceptor blockade in patients with essential hypertension may be explained by a reduction in sympathetic tone and by reduced activity of the renin-aldosterone system.
No takes yet. Share an insight, caveat, or question.
Fritschka et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: